ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610456 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610456; 2) Community: the network communities that were significantly associated with the response to NSC 610456; 3) Molecule: the relationships between components within communities and NSC 610456; 4) MDR: the compounds that were significantly associated with the NSC 610456.

NSC Compound Enrichment Correlation
NSC 676372 Null 0.00404192617431249 0.053892425
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.00404192617431249 0.12057388
NSC 679800 Null 0.00404192617431249 0.19988546
NSC 681645 Camptothecin Derivative 0.00404192617431249 0.88254958
NSC 684440 Null 0.00404192617431249 0.53589
NSC 685862 Null 0.00404192617431249 0.24138316
NSC 690270 ANTINEOPLASTIC-690270 0.00404192617431249 0.42318396
NSC 724994 2-[(Dimethylamino)-1-ethyl]-5,6-dihydro-2,3-dimethoxy-8,9-me thylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Formic Acid 0.00404192617431249 0.78192035
NSC 725774 6-[3-(Bis-hydroxyethylamino)-1-propyl]-5,6-dihydro-2,3-~ dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline hydrochloride 0.00404192617431249 0.70264386
NSC 735037 Camptothecin Derivative 0.00404192617431249 0.84937601
Total:96  Current:11    [First] [Prev] [Next] [Last]